BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4799026)

  • 1. [Lymphocyte transformation test and migration inhibition test of macrophages in Vogt-Koyanagi-Hirada's syndrome (author's transl)].
    Yuasa T; Murai Y; Hoki T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1973 Oct; 77(10):1652-7. PubMed ID: 4799026
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody-dependent cell-mediated cytotoxicity (ADCC) against melanocyte antigens in Vogt-Koyanagi-Harada disease (author's transl)].
    Tagawa Y; Sugiura S
    Nippon Ganka Gakkai Zasshi; 1977 Aug; 81(8):1101-4. PubMed ID: 930771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some observations on uveitis in Japan, with special reference to Vogt-Koyanagi-Harada and Behçet diseases (author's transl)].
    Sugiura S
    Nippon Ganka Gakkai Zasshi; 1976 Nov; 80(11):1285-326. PubMed ID: 1034425
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lymphocyte transformation test in Vogt-Koyanagi-Harada syndrome (author's transl)].
    Momoeda S
    Nippon Ganka Gakkai Zasshi; 1976 Aug; 80(8):491-6. PubMed ID: 988721
    [No Abstract]   [Full Text] [Related]  

  • 5. [Identification of antibody-producing cells in peripheral lymphocytes of Vogt-Koyanagi-Harada's syndrome with immunocyte adherence (rosette-formation) technique (author's transl)].
    Yuasa T; Matsumoto K; Hoki T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1975 Oct; 79(10):1389-92. PubMed ID: 1239165
    [No Abstract]   [Full Text] [Related]  

  • 6. [Existence of cytotoxic T lymphocytes specific for human melanoma cells in Vogt-Koyanagi-Harada disease (author's transl)].
    Maezawa N
    Nippon Ganka Gakkai Zasshi; 1981 Sep; 85(9):1406-11. PubMed ID: 6976680
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cell-mediated immunity in uveitis. 2. Leukocyte migration inhibition test in Harada's disease (author's transl)].
    Sanefuji M
    Nippon Ganka Gakkai Zasshi; 1974 Jun; 78(6):306-10. PubMed ID: 4471763
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte transformation test in sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome.
    Hammer H
    Br J Ophthalmol; 1971 Dec; 55(12):850-2. PubMed ID: 5168516
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular hypersensitivity to uveal pigment confirmed by leucocyte migration tests in sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome.
    Hammer H
    Br J Ophthalmol; 1974 Sep; 58(9):773-6. PubMed ID: 4473998
    [No Abstract]   [Full Text] [Related]  

  • 10. [Surface marker studies on the activated peripheral blood lymphocytes of Vogt-Koyanagi-Harada's disease].
    Okubo K; Kurimoto S; Okubo K; Yokoyama MM
    Nippon Ganka Gakkai Zasshi; 1985 Feb; 89(2):358-63. PubMed ID: 3873787
    [No Abstract]   [Full Text] [Related]  

  • 11. [Involvement of Ia-positive accessory cells for activation of cytotoxic T lymphocyte specific for melanocyte-associated antigens in patients with Vogt-Koyanagi-Harada disease].
    Maezawa N; Tsukahara S
    Nippon Ganka Gakkai Zasshi; 1985 Mar; 89(3):440-6. PubMed ID: 3874531
    [No Abstract]   [Full Text] [Related]  

  • 12. [Investigation of interferon system in Vogt-Koyanagi-Harada disease].
    Ohno S; Kotake S; Fjuii N; Minagawa T
    Nippon Ganka Gakkai Zasshi; 1982; 86(10):1574-80. PubMed ID: 6187194
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: HLA and Vogt-Koyanagi-Harada syndrome.
    Tagawa Y; Sugiura S; Yakura H; Wakisaka A; Aizawa M
    N Engl J Med; 1976 Jul; 295(3):173. PubMed ID: 1272341
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunopathological and clinical studies on ocular allergic diseases (author's transl)].
    Mimura Y; Yuasa T; Bando K; Matsumoto K; Moriyama H
    Nippon Ganka Gakkai Zasshi; 1979; 83(10):1909-75. PubMed ID: 546185
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cellular immunity in patients with Vogt-Koyanagi-Harada syndrome].
    Xie CF; Huang XK; Wen SD
    Yan Ke Xue Bao; 1988 Jun; 4(2):118-20. PubMed ID: 3240811
    [No Abstract]   [Full Text] [Related]  

  • 16. [The association between major histocompatibility antigens (HLA) and Vogt-Koyanagi-Harada syndrome (author's transl)].
    Tagawa Y; Sugiura S; Yakura H; Wakisaka A; Aizawa M
    Nippon Ganka Gakkai Zasshi; 1976 Aug; 80(8):486-90. PubMed ID: 988720
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ultrastructural changes of skin in Vogt-Koyanagi-Harada Syndrome (author's transl)].
    Igarashi M; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1976 Dec; 80(12):1603-9. PubMed ID: 1035474
    [No Abstract]   [Full Text] [Related]  

  • 18. [A statistic study of Vogt-Koyanagi-Harada syndrome (author's transl)].
    Fujioka T; Fukuda M; Okinami S
    Nippon Ganka Gakkai Zasshi; 1980 Nov; 84(11):1979-82. PubMed ID: 7246357
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell mediated immunity to human myelin basic protein in Vogt-Koyahagi-Harada syndrome.
    Manor RS; Livni E; Cohen S
    Invest Ophthalmol Vis Sci; 1979 Feb; 18(2):204-6. PubMed ID: 83972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of interferon in the sera and cerebrospinal fluid of patients with Vogt-Koyanagi-Harada disease (author's transl)].
    Kato F; Ohno S; Matsuda H; Fujii N; Minagawa T
    Nippon Ganka Gakkai Zasshi; 1981 Mar; 85(3):217-21. PubMed ID: 6168187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.